首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1
【24h】

Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1

机译:尿比重基因SLC14A1中尿比重的差异作为膀胱癌遗传关联的分子表型

获取原文
获取原文并翻译 | 示例
       

摘要

Genome-wide association studies (GWAS) identified associations between markers within the solute carrier family 14 (urea transporter), member 1 (SLC14A1) gene and risk of bladder cancer. SLC14A1 defines the Kidd blood groups in erythrocytes and is also involved in concentration of the urine in the kidney. We evaluated the association between a representative genetic variant (rs10775480) of SLC14A1 and urine concentration, as measured by urinary specific gravity (USG), in a subset of 275 population-based controls enrolled in the New England Bladder Cancer Study. Overnight urine samples were collected, and USG was measured using refractometry. Analysis of covariance was used to estimate adjusted least square means for USG in relation to rs10775480. We also examined the mRNA expression of both urea transporters, SLC14A1 and SLC14A2, in a panel of human tissues. USG was decreased with each copy of the rs10775480 risk T allele (p-trend = 0.011) with a significant difference observed for CC vs. TT genotypes (p-valuetukey = 0.024). RNA-sequencing in the bladder tissue showed high expression of SLC14A1 and the absence of SLC14A2, while both transporters were expressed in the kidney. We suggest that the molecular phenotype of this GWAS finding is the genotype-specific biological activity of SLC14A1 in the bladder tissue. Our data suggest that SLC14A1 could be a unique urea transporter in the bladder that has the ability to influence urine concentration and that this mechanism might explain the increased bladder cancer susceptibility associated with rs10775480.
机译:全基因组关联研究(GWAS)确定了溶质载体家族14(尿素转运蛋白),成员1(SLC14A1)基因内的标志物与膀胱癌风险之间的关联。 SLC14A1定义了红细胞中的Kidd血型,并且还参与了肾脏中尿液的浓缩。我们评估了SLC14A1的代表性遗传变异(rs10775480)与尿液浓度之间的关联性,该尿液浓度通过尿液比重(USG)进行了测定,纳入了新英格兰膀胱癌研究的275个基于人群的对照组中。收集隔夜尿液样品,并使用折光仪测量USG。使用协方差分析来估计相对于rs10775480的USG调整后的最小二乘均值。我们还检查了一组人体组织中两种尿素转运蛋白SLC14A1和SLC14A2的mRNA表达。每份rs10775480风险T等位基因(p-趋势= 0.011)的USG均降低,在CC和TT基因型之间观察到显着差异(p-valuetukey = 0.024)。膀胱组织中的RNA测序显示SLC14A1的高表达而SLC14A2的不存在,而两种转运蛋白均在肾脏中表达。我们建议,此GWAS发现的分子表型是膀胱组织中SLC14A1的基因型特异性生物活性。我们的数据表明,SLC14A1可能是膀胱中独特的尿素转运蛋白,具有影响尿液浓度的能力,并且该机制可能解释了与rs10775480相关的膀胱癌易感性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号